A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.

Rongyu Zang,Jianqing Zhu,Tingyan Shi,Jihong Liu,Dongsheng Tu,Sheng Yin,Rong Jiang,Ping Zhang,Huixun Jia,Yuting Luan,Yuqin Zhang,Xiaojun Chen,Xiao Huang,Wenjuan Tian,Wen Gao,Yanling Feng,Huijuan Yang,Xi Cheng,Yulang Cai

A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.

2020

Rongyu Zang
Jianqing Zhu
Tingyan Shi
Jihong Liu
Dongsheng Tu
Sheng Yin
Rong Jiang
Ping Zhang
Huixun Jia
Yuting Luan
Yuqin Zhang
Xiaojun Chen
Xiao Huang
Wenjuan Tian
Wen Gao
Yanling Feng
Huijuan Yang
Xi Cheng
Yulang Cai

6001Background: In China, secondary cytoreductive surgery (SCR) has been standard of care in some high volume cancer centers for ovarian cancer (OC) and most pts prefer surgery over the past two de...

Keywords:

cytoreductive surgery
Surgery
Pathology
Medicine
Recurrent Ovarian Cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations